Abstract
Estrogen regulates hypothalamic gene expression, synthesis and release of the endogenous opioid peptide β-endorphin (βEND), although a consensus estrogen response element sequence has not been identified in the rat proopiomelanocortin (POMC) gene. POMC gene expression is also regulated by the activation of AP-1 promoter elements, which are known to be estrogen sensitive. The present studies examine whether estrogen modulates the hypothalamic POMC system through a non-classical mechanism involving AP-1 binding proteins such as cFos. Immunohistochemical double-labeling for βEND and cFos was used and immunoreactive (-ir) populations were quantified in the arcuate nucleus and periarcuate area across time using unbiased stereological methods. Ovariectomized rats were injected with 50 µg estradiol (E2), 500 µg tamoxifen citrate (TAM) or both (E2+TAM) and were perfused 1, 2, 4 or 48 h later. E2 rapidly increased numbers of cFos-ir, βEND-ir and doubly-labeled cells after 4 h, and the number of βEND-ir cells remained high 48 h later, suggesting that the stimulatory effects of cFos on POMC in the hypothalamus persist after the cFos signal decays. Treatment with TAM alone did not affect the numbers of immunoreactive cells, although E2+TAM blocked the E2-mediated induction in all immunoreactive populations. Similar effects were seen at the transcriptional level. E2 increased hypothalamic POMC mRNA after 4 h, while TAM treatment or coadministration of E2+TAM did not significantly change the levels of POMC mRNA. Cellular colocalization of βEND-ir and cFos-ir supports a possible intracellular co-regulation of these peptides by an estrogen-dependent mechanism within a subset of hypothalamic neurons. It does not, however, appear that E2 acts directly through an AP-1 site within the POMC gene.
References
1.
Wise PM, Scarbrough K, Weiland NG, Larson GH: Diurnal pattern of proopiomelanocortin gene expression in the arcuate nucleus of proestrous, ovariectomized, and steroid-treated rats: A possible role in cyclic luteinizing hormone secretion. Mol Endocrinol 1990;4:886–892.
2.
Bohler HC, Tracer H, Merriam GR, Petersen SL: Changes in proopiomelanocortin messenger ribonucleic acid levels in the rostral periarcuate region of the female rat during the estrous cycle. Endocrinology 1991;128:1265–1269.
3.
Wilcox JN, Roberts JL: Estrogen decreases rat hypothalamic proopiomelanocortin messenger ribonucleic acid levels. Endocrinology 1985;117:2392–2396.
4.
Treiser SL, Wardlaw SL: Estradiol regulation of proopiomelanocortin gene expression and peptide content in the hypothalamus. Neuroendocrinology 1992;55:167–173.
5.
Tong Y, Zhao HF, Labrie F, Pelletier G: Regulation of proopiomelanocortin messenger ribonucleic acid content by sex steroids in the arcuate nucleus of the female rat brain. Neurosci Lett 1990;112:104–108.
6.
Eipper BA, Mains RE: Structure and biosynthesis of pro-andrenocorticotropin/endorphin and related peptides. Endocr Rev 1980;1:1–16.
7.
Bloom F, Battenberg E, Rossier J, Ling N, Guillemin R: Neurons containing beta-endorphin in rat brain exist separately from those containing enkephalin: Immunocytochemical studies. Proc Natl Acad Sci USA 1978;75:1591–1595.
8.
Watson SJ, Akil H, Walker JM: Anatomical and biochemical studies of the opioid peptides and related substances in the brain. Peptides 1980;1:11–20.
9.
Gee CE, Chen CL, Roberts JL, Thompson R, Watson SJ: Identification of proopiomelanocortin neurones in rat hypothalamus by in situ cDNA-mRNA hybridization. Nature 1983;306:374–376.
10.
Mezey E, Kiss J, Mueller G, Eskay R, O’Donohue T, Palkovits M: Distribution of the pro-opiomelanocortin derived peptides, adrenocorticotrope hormone, alpha-melanocyte stimulating hormone and beta-endorphin (ACTH, α-MSH, βEND) in the rat hypothalamus. Brain Res 1985; 328:341–347.
11.
Wilcox JN, Roberts JL, Chronwall BM, Bishop JF, O’Donogue T: Localization of proopiomelanocortin mRNA in functional subsets of neurons defined by their axonal projections. J Neurosci Res 1986;16:89–96.
12.
Leranth C, MacLusky N, Shanabrough M, Naftolin F: Immunohistochemical evidence for synaptic connections between pro-opiomelanocortin-immunoreactive axons and LH-RH neurons in the preoptic area of the rat. Brain Res 1988;449:167–176.
13.
Chen W-P, Witkin J, Silverman A-J: Beta-endorphin and gonadotropin releasing hormone synaptic input to gonadotropin-releasing hormone neurosecretory cells in the male rat. J Comp Neurol 1989;286:85–95.
14.
Cheung S, Hammer RP: Gonadal steroid hormone regulation of proopiomelanocortin gene expression in arcuate neurons that innervate the medial preoptic area of the rat. Neuroendocrinology 1995;62:283–292.
15.
Barraclough CA, Sawyer CH: Inhibition of the release of pituitary ovulatory hormone in the rat by morphine. Endocrinology 1955;57:329–337.
16.
Kubo K, Kiyota , Fukunaga S: Effects of third ventricular injection of beta-endorphin on luteinizing hormone surges in female rat: Sites and mechanisms of opioid actions in the brain. Endocrinol Jpn 1983;30:419–433.
17.
Wiesner JB, Koenig JI, Krulich L, Moss RL: Site of action for beta-endorphin-induced changes in plasma luteinizing hormone and prolactin in the ovariectomized rat. Life Sci 1984;34:1463–1473.
18.
Leadem CA, Kalra SP: Effects of endogenous opioid peptides and opiates on luteinizing hormone and prolactin secretion in ovariectomized rats. Neuroendocrinology 1985;41:342–352.
19.
Desjardins GC, Brawer JR, Beaudet A: Estradiol is selectively neurotoxic to hypothalamic beta-endorphin neurons. Endocrinology 1993;132:86–93.
20.
Thornton JE, Loose MD, Kelly MJ, Ronnekleiv OK: Effects of estrogen on the number of neurons expressing beta-endorphin in the medial basal hypothalamus of the female guinea pig. J Comp Neurol 1994;341:68–77.
21.
Miller MM, Tousignant P, Yang U, Pedvis S, Billiar RB: Effects of age and long-term ovariectomy on the estrogen-receptor containing subpopulations of beta-endorphin-immunoreactive neurons in the arcuate nucleus of female C57BL/6J mice. Neuroendocrinology 1995;61:542–551.
22.
Dupont A, Barden N, Cusan L, Merand Y, Labrie F, Vaudry H: Beta-endorphin and met-enkephalins: Their distribution, modulation by estrogens and haloperidol, and role in neuroendocrine control. Fed Proc 1980;39:2544–2550.
23.
Barden N, Merand Y, Rouleau P, Garon M, Dupont A: Changes in the beta-endorphin content of discrete hypothalamic nuclei during the estrous cycle of the rat. Brain Res 1981;204:441–445.
24.
Forman LJ, Sonntag WE, Hylka VW, Meites J: Mediation by gonadal steroids of plasma beta-endorphin and LH in castrated female and male rats. Peptides 1985;6:835–839.
25.
Wardlaw SL, Wang PJ, Frantz AG: Regulation of beta-endorphin and ACTH in brain by estradiol. Life Sci 1985;37:1941–1947.
26.
Mueller GP: Attenuated pituitary beta-endorphin release in estrogen-treated rats. Proc Soc Exp Biol Med 1980;165:75–81.
27.
Nakano Y, Suda T, Sumitomo T, Tozawa F, Demura H: Effects of sex steroids on beta-endorphin release from rat hypothalamus in vitro. Brain Res 1991;553:1–3.
28.
Morrell JI, McGinty JF, Pfaff DW: A subset of beta-endorphin- or dynorphin-containing neurons in the medial basal hypothalamus accumulates estradiol. Neuroendocrinology 1985;41:417–426.
29.
Jirikowski GF, Merchenthaler I, Rieger GE, Stumpf WE: Estradiol target sites immunoreactive for beta-endorphin in the arcuate nucleus of rat and mouse hypothalamus. Neurosci Lett 1986;65:121–126.
30.
Drouin J, Chamberland M, Charron J, Jeannotte L, Nemer M: Structure of the rat proopiomelanocortin gene. FEBS Lett 1985;193:54–58.
31.
Beato M, Arnemann G, Chalepakis G, Slater E, Willmann T: Gene regulation by steroid hormones. J Steroid Biochem 1987;27:9–14.
32.
Evans RM: The steroid and thyroid hormone receptor superfamily. Science 1988;240:889–895.
33.
Boutillier AL, Sassone-Corsi P, Loeffler JP: The protooncogene c-fos is induced by corticotropin-releasing factor and stimulates proopiomelanocortin gene transcription in pituitary cells. Mol Endocrinol 1991;5:1301–1310.
34.
Boutillier AL, Barthel F, Roberts JL, Loeffler JP: Beta-adrenergic stimulation of cFos via protein kinase A is mediated by cAMP regulatory element binding protein (CREB)-dependent and tissue-specific CREB-independent mechanisms in corticotrope cells. J Biol Chem 1992;267:23520–23526.
35.
Autelitano DJ, Sheppard KE: Corticotrope responsiveness to glucocorticoids is modulated via rapid CRF-mediated induction of the proto-oncogene c-fos. Mol Cell Endocrinol 1993;94:111–119.
36.
Boutillier AL, Monnier D, Lorang D, Lundblad JR, Roberts JL, Loeffler JP: Corticotropin-releasing hormone stimulates proopiomelanocortin transcription by cFos-dependent and -independent pathways: Characterization of an AP1 site in exon 1. Mol Endocrinol 1995;9:745–755.
37.
Loose-Mitchell DS, Chiappetta C, Stancel GM: Estrogen regulation of c-fos messenger ribonucleic acid. Mol Endocrinol 1988;2:946–951.
38.
Weisz A, Bresciani F: Estrogen induces expression of c-fos and c-myc protooncogenes in rat uterus. Mol Endocrinol 1988;2:816–824.
39.
Insel TR: Regional induction of c-fos-like protein in rat brain after estradiol administration. Endocrinology 1990;126:1849–1853.
40.
Webb P, Lopez GN, Uht RM, Kushner PJ: Tamoxifen activation of the estrogen receptor/AP-1 pathway: Potential origin for the cell-specific estrogen-like effects of antiestrogens. Mol Endocrinol 1995;9:443–456.
41.
Uht RM, Anderson CM, Webb P, Kushner PJ: Transcriptional activities of estrogen and glucocorticoid receptors are functionally integrated at the AP-1 response element. Endocrinology 1997;138:2900–2908.
42.
Paech K, Webb P, Kuiper GGJM, Nilsson S, Gustafsson J-A, Kushner PJ, Scanlan TS: Differential ligand activation of estrogen receptors ERα and ERβ at AP1 sites. Science 1997;277:1508–1510.
43.
Shughrue PJ, Lane MV, Merchenthaler I: Comparative distribution of estrogen receptor-α and -β mRNA in the rat central nervous system. J Comp Neurol 1997;388:507–525.
44.
Priest CA, Eckersell CB, Micevych PE: Estrogen regulates preproenkephalin-A mRNA levels in the rat ventromedial nucleus: Temporal and cellular aspects. Mol Brain Res 1995;28:251–262.
45.
Priest CA, Vink KL, Micevych PE: Temporal regulation by estrogen of β-preprotachykinin mRNA expression in the rat ventromedial nucleus of the hypothalamus. Mol Brain Res 1995;28:61–71.
46.
Waters AP, Knowler JT: A comparison of the effects of oestrogen and tamoxifen on the synthesis of uterine RNA in immature rats. J Steroid Biochem 1980;14:625–630.
47.
Wakeling AE, Bowler J: Novel antioestrogens without partial agonist activity. J Steroid Biochem 1988;31:645–653.
48.
Kirkland, JL, Murthy L, Stancel GM: Tamoxifen stimulates expression of the c-fos proto-oncogene in rodent uterus. Mol Pharmacol 1993;43:709–714.
49.
Nephew KP, Polek TC, Akcali KC, Khan SA: The antiestrogen tamoxifen induces c-fos and jun-B but not c-jun or jun-D, protooncogenes in the rat uterus. Endocrinology 1993;133:419–422.
50.
de Olmos JS, Hardy H, Heimer L: The afferent connections of the main and accessory olfactory bulb formations in the rat. An experimental HRP study. J Comp Neurol 1978;181:213–244.
51.
Watson RE, Wiegand SJ, Clough RW, Hoffman GE: Use of cryoprotectant to maintain long-term peptide immunoreactivity and tissue morphology. Peptides 1986;7:155–159.
52.
Bloom FE, Young WG, Nimchinsky EA, Hof PR, Morrison JH: Neuronal vulnerability and informatics in human disease; in Koslow SH, Huerta MF (eds): Progress in Neuroinformatics Research. Vol 1: Neuroinformatics – An Overview of the Human Brain Project. Mahwahl, Erlbaum, 1997, pp 83–123.
53.
West MJ: New stereological methods for counting neurons. Neurobiol Aging 1993;14:275–285.
54.
Levin N, Blum M, Roberts JL: Modulation of basal and corticotropin-releasing factor-stimulated proopiomelanocortin gene expression by vasopressin in rat anterior pituitary. Endocrinology 1989;125:2957–2966.
55.
Jakubowski M, Roberts JL: Multiplex solution hybridization-ribonuclease protection assay for quantitation of different ribonucleic acid transcripts from snap-frozen neuroendocrine tissues of individual animals. J Neuroendocrinol 1992;4:79–89.
56.
Scarbrough K, Jakubowski M, Levin N, Wise PM, Roberts JL: The effect of time of day on levels of hypothalamic proopiomelanocortin primary transcript, processing intermediate and messenger ribonucleic acid in proestrous and estrous rats. Endocrinology 1994;134:555–561.
57.
Cheung S, Salinas J, Hammer RP: Gonadal steroid hormone-dependence of beta-endorphin-like immunoreactivity in the medial preoptic area of the rat. Brain Res 1995;675:83–88.
58.
Rosie R, Thomson E, Blum M, Roberts JL, Fink G: Oestrogen positive feedback reduces arcuate proopiomelanocortin messenger ribonucleic acid. J Neuroendocrinol 1992;4:626–630.
59.
Ambrosino C, Cicatiello L, Cobellis G, Addeo R, Sica V, Bresciani F, Weisz A: Functional antagonism between the estrogen receptor and Fos in the regulation of c-fos protooncogene transcription. Mol Endocrinol 1993;7:1472–1483.
60.
Lerant A, Freeman ME: Dopaminergic neurons in periventricular and arcuate nuclei of proestrous and ovariectomized rats: Endogenous diurnal rhythm of fos-related antigens expression. Neuroendocrinology 1997;65:436–445.
61.
Parnet P, Lenoir V, Palkovits M, Kerdelhué: Estrous cycle variations in gonadotropin-releasing hormone, substance P and beta-endorphin contents in the median eminence, the arcuate nucleus and the medial preoptic nucleus in the rat: A detailed analysis of proestrus changes. J Neuroendocrinol 1990;2:291–296.
62.
Simerly RB, Young BJ: Regulation of estrogen receptor messenger ribonucleic acid in rat hypothalamus by sex steroid hormones. Mol Endocrinol 1991;5:424–432.
63.
Zarrow MX, Yochim JM, McCarthy JL: Experimental Endocrinology: A Sourcebook of Basic Techniques. New York, Academic Press, 1964.
64.
Lima D, Avelino A, Coimbra A: Differential activation of c-fos in spinal neurones by distinct classes of noxious stimuli. Neuroreport 1993;4:747–750.
65.
Asanuma M, Ogawa N: Pitfalls in assessment of c-fos mRNA expression in the brain: Effects of animal handling. Rev Neurosci 1994;5:171–178.
66.
Alexander MJ: Estrogen-related synthesis of neurotensin in neurosecretory cells of the hypothalamic arcuate nucleus in the female rat. Endocrinology 1993;133:1809–1816.
67.
Drouin J, Goodman HM: Most of the coding region of rat ACTH beta-LPH precursor gene lacks intervening sequences. Nature 1980;288:610.
68.
Kato S, Tora L, Yamauchi J, Masushiege S, Bellard M, Chambon P: A far upstream estrogen response element of the ovalbumin gene contains several half-palindromic 5′-TGACC-3′ motifs acting synergistically. Cell 1992;68:731–742.
69.
Rishi AK, Shao ZM, Baumann RG, Li XS, Sheikh MS, Kimura S, Bashirelahi N, Fontana JA: Estradiol regulation of the human retinoic acid receptor alpha gene in human breast carcinoma cells is mediated via an imperfect half-palindromic estrogen response element and Sp1 motifs. Cancer Res 1995;55:4999–5006.
70.
Paxinos G, Watson C: The Rat Brain in Stereotaxic Coordinates, ed 2. San Diego, Academic Press, 1986.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.
